Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05862649Not ApplicableCompleted

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

Role: lead

NCT05476523Recruiting

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Role: lead

NCT06597071Not ApplicableEnrolling By Invitation

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

Role: lead

NCT05407428Completed

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients

Role: lead

NCT05795023Not ApplicableCompleted

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Role: lead

NCT05437003Not ApplicableCompleted

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients

Role: lead

All 6 trials loaded